Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 301 AL 315

Amyloid-β Receptors: The Good, the Bad, and the Prion Protein

Jarosz-Griffiths HH, Noble E, Rushworth JV, Hooper NM.

J Biol Chem. 2016 Feb 12;291(7):3174-83. doi: 10.1074/jbc.R115.702704. Epub 2015 Dec 30.

Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets

Han SH, Park JC, Mook-Jung I.

Prog Neurobiol. 2016 Feb;137:17-38. doi: 10.1016/j.pneurobio.2015.12.004. Epub 2015 Dec 23.

Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds

Singh SK, Srivastav S, Yadav AK, Srikrishna S, Perry G.

Oxid Med Cell Longev. 2016;2016:7361613. doi: 10.1155/2016/7361613. Epub 2015 Dec 28.

Higher Frequency and Complexity of Sleep Disturbances in Dementia with Lewy Bodies as Compared to Alzheimer's Disease

Chwiszczuk L, Breitve M, Hynninen M, Gjerstad MD, Aarsland D, Rongve A.

Neurodegener Dis. 2016;16(3-4):152-60. doi: 10.1159/000439252. Epub 2015 Nov 10.

Unlocking Electronic Medical Record Data to Identify Possible Connections Between Cancer and Cognitive Declines

McGinty HL.

J Clin Oncol. 2016 Feb 20;34(6):530-2. doi: 10.1200/JCO.2015.65.2248. Epub 2015 Dec 28.

Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus

Bozluolcay M, Andican G, Fırtına S, Erkol G, Konukoglu D.

Geriatr Gerontol Int. 2016 Oct;16(10):1161-1166. doi: 10.1111/ggi.12602. Epub 2015 Sep 3.

Salvia miltiorrhiza: A source for anti-Alzheimer's disease drugs

Zhang XZ, Qian SS, Zhang YJ, Wang RQ.

Pharm Biol. 2016;54(1):18-24. doi: 10.3109/13880209.2015.1027408. Epub 2015 Apr 10.

Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation

Kudoh C, Arita R, Honda M, Kishi T, Komatsu Y, Asou H, Mimura M.

Psychogeriatrics. 2016 Mar;16(2):85-92. doi: 10.1111/psyg.12125. Epub 2015 Apr 27.

Neuronal histamine and cognitive symptoms in Alzheimer's disease

Zlomuzica A, Dere D, Binder S, De Souza Silva MA, Huston JP, Dere E.

Neuropharmacology. 2016 Jul;106:135-45. doi: 10.1016/j.neuropharm.2015.05.007. Epub 2015 May 27.

Safety and pharmacokinetics of bapineuzumab in a single ascending-dose study in Japanese patients with mild to moderate Alzheimer's disease

Arai H, Umemura K, Ichimiya Y, Iseki E, Eto K, Miyakawa K, Kirino E, Shibata N, Baba H, Tsuchiwata S.

Geriatr Gerontol Int. 2016 May;16(5):644-50. doi: 10.1111/ggi.12516. Epub 2015 Jun 4.

Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimer's disease: interim results from the long-term, large-scale J-GOLD study in Japan

Arai H, Sumitomo K, Sakata Y, Daidoji K, Takase T, Toyoda T.

Psychogeriatrics. 2016 Mar;16(2):107-15. doi: 10.1111/psyg.12130. Epub 2015 Jun 26.

Current and novel therapeutic molecules and targets in Alzheimer's disease

Kumar A, Nisha CM, Silakari C, Sharma I, Anusha K, Gupta N, Nair P, Tripathi T, Kumar A.

J Formos Med Assoc. 2016 Jan;115(1):3-10. doi: 10.1016/j.jfma.2015.04.001. Epub 2015 Jul 26.

Time to Treatment Initiation in People With Alzheimer Disease: A Meta-Analysis of Randomized Controlled Trials

Tsoi KK, Hirai HW, Chan JY, Kwok TC.

J Am Med Dir Assoc. 2016 Jan;17(1):24-30. doi: 10.1016/j.jamda.2015.08.007. Epub 2015 Sep 26.

Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease

Choe YM, Kim KW, Jhoo JH, Ryu SH, Seo EH, Sohn BK, Byun MS, Bak JH, Lee JM, Yun HJ, Han MI, Woo JI, Lee DY.

Int J Geriatr Psychiatry. 2016 Jul;31(7):731-9. doi: 10.1002/gps.4384. Epub 2015 Nov 9.

The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease

Ishikawa I, Shinno H, Ando N, Mori T, Nakamura Y.

Acta Neuropsychiatr. 2016 Jun;28(3):157-64. doi: 10.1017/neu.2015.61. Epub 2015 Nov 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias